Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Oncogenic Potential of Replication Factor C Subunit 4: Correlations with Tumor Progression and Assessment of Potential Inhibitors

23 Jan 2024

Abstract excerpt

Replication Factor C Subunit 4 (RFC4), an oncogene implicated in many human cancers, has yet to be extensively studied in many cancer types to determine its expression patterns and tumor tissue function. Various bioinformatics tools were used to analyze RFC4 as a potential oncogene and therapeutic target across many cancers. We first examined RFC4 expression levels in several human tumor types to determine...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Immunotherapy and Biomarkers
Share to Epigenetics and DNA Methylation
Share to RNA modifications and cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 38399367
DOI: 10.3390/ph17020152

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Oncogenic Potential of Replication Factor C Subunit 4: Correlations with Tumor Progression and Assessment of Potential InhibitorsPMID 38399367Read ↗

Replication Factor C Subunit 4 Plays a Role in Human Breast Cancer Cell ProgressionSemantic proximity Read ↗

Identification of RFC4 as a potential biomarker for pan‐cancer involving prognosis, tumour immune microenvironment and drugsSemantic proximity Read ↗

Multi-omics pan-cancer analyses identify MCM4 as a promising prognostic and diagnostic biomarkerSemantic proximity Read ↗

A Comprehensive Bioinformatic Analysis of RFC1/2/3/4/5 As Significant Clinical Indicators in The Diagnosis and Prognosis of Low-Grade GliomaSemantic proximity Read ↗

DSCC1 Identified as Promising Tumor Biomarker and Potential Therapeutic Target Through Comprehensive Multi-omics Analysis and Experimental Validation.Semantic proximity Read ↗

Clinical evidence for a role of E2F1-induced replication stress in modulating tumor mutational burden and immune microenvironment.Semantic proximity Read ↗

RFC2: a prognosis biomarker correlated with the immune signature in diffuse lower-grade gliomasSemantic proximity Read ↗

Gene expression profiling, prognosis, and immune microenvironment of KLF4 in malignanciesSemantic proximity Read ↗

Special issue "The advance of solid tumor research in China": FGFR4 alterations predict efficacy of immune checkpoint inhibitors in nonsmall cell lung cancer.Semantic proximity Read ↗

Integrative and Comprehensive Pancancer Analysis of Regulator of Chromatin Condensation 1 (RCC1)Semantic proximity Read ↗

Comprehensive analysis of the expression profile and clinical implications of regulator of chromosome condensation 2 in pan-cancersSemantic proximity Read ↗

Multi-Omics Analysis of MCM2 as a Promising Biomarker in Pan-CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.